多功能水凝用于治疗糖尿病伤口
Tao Xiang1,2, Qianru Guo1,2, Lianghao Jia1,2
1Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, 610031, P. R. China.
Advanced healthcare materials
|September 13, 2023
概括
智能水凝通过解决细菌感染,炎症和氧化应激,为糖尿病伤口愈合提供多功能解决方案. 这些先进材料通过针对伤口微环境的量身定制反应促进更快的愈合.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 糖尿病伤口愈合受到感染,炎症,氧化应激和缺氧等因素的影响.
- 目前的治疗方法往往无法解决糖尿病伤口的复杂微观环境.
- 需要先进的治疗策略来克服治愈障碍.
研究的目的:
- 审查具有多功能能力的智能水凝,用于糖尿病伤口愈合.
- 讨论将各种治疗策略整合到这些水凝中.
- 为制造和应用这些水凝在糖尿病伤口修复中提供准则.
主要方法:
- 关于智能水凝及其特性 (响应刺激,自我愈合,形状记忆,导电,监测) 的文献综述.
- 分析这些特性如何应对糖尿病伤口的微环境挑战.
- 综合策略的讨论:抗菌,抗炎,免疫调节,抗氧化,亲血管.
主要成果:
- 智能水凝可以设计出多种功能,以动态响应糖尿病伤口微环境.
- 多功能水凝可以同时解决关键的愈合障碍,如感染和炎症.
- 这些水凝显示了实时监测和量身定制的治疗交付的潜力.
结论:
- 智能,多功能水凝代表了一种有前途的治疗方法,可以加速糖尿病伤口愈合.
- 根据糖尿病伤口微环境的特定需求量身定制水凝功能对于疗效至关重要.
- 需要进一步的研究和开发,才能将这些先进的水凝转化为临床实践.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


